[go: up one dir, main page]

GB0015999D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0015999D0
GB0015999D0 GBGB0015999.6A GB0015999A GB0015999D0 GB 0015999 D0 GB0015999 D0 GB 0015999D0 GB 0015999 A GB0015999 A GB 0015999A GB 0015999 D0 GB0015999 D0 GB 0015999D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0015999.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB0015999.6A priority Critical patent/GB0015999D0/en
Publication of GB0015999D0 publication Critical patent/GB0015999D0/en
Priority to HU0301413A priority patent/HU228384B1/en
Priority to AT01960390T priority patent/ATE534402T1/en
Priority to BR122012003821A priority patent/BR122012003821B8/en
Priority to OA1200200395A priority patent/OA12302A/en
Priority to HU1000593A priority patent/HU227893B1/en
Priority to CN018146198A priority patent/CN1449293B/en
Priority to APAP/P/2002/002700A priority patent/AP1695A/en
Priority to CZ20024224A priority patent/CZ20024224A3/en
Priority to SI200131007T priority patent/SI1296715T2/en
Priority to PL393584A priority patent/PL393584A1/en
Priority to SK1843-2002A priority patent/SK288007B6/en
Priority to ES01960390.1T priority patent/ES2375704T5/en
Priority to SI200131012T priority patent/SI1946769T1/en
Priority to DK07116669.8T priority patent/DK1946769T3/en
Priority to KR1020027017928A priority patent/KR100837917B1/en
Priority to DZ013399A priority patent/DZ3399A1/en
Priority to AU2001281895A priority patent/AU2001281895C1/en
Priority to PCT/EP2001/007288 priority patent/WO2002000249A2/en
Priority to AU8189501A priority patent/AU8189501A/en
Priority to UY26801A priority patent/UY26801A1/en
Priority to IL15350601A priority patent/IL153506A0/en
Priority to EP10178451A priority patent/EP2277541A1/en
Priority to CA2412497A priority patent/CA2412497C/en
Priority to EP10178449A priority patent/EP2279748A1/en
Priority to NZ523319A priority patent/NZ523319A/en
Priority to CA2783274A priority patent/CA2783274C/en
Priority to UA20021210397A priority patent/UA76952C2/en
Priority to PL360265A priority patent/PL210015B1/en
Priority to CN200910174266.7A priority patent/CN101708333B/en
Priority to HU1000594A priority patent/HU227613B1/en
Priority to US10/312,090 priority patent/US20030180316A1/en
Priority to KR1020077019832A priority patent/KR20070091698A/en
Priority to PT01960390T priority patent/PT1296715E/en
Priority to BRPI0112057A priority patent/BRPI0112057B8/en
Priority to JP2002505030A priority patent/JP4870895B2/en
Priority to UAA200604994A priority patent/UA85853C2/en
Priority to MYPI20013027 priority patent/MY133981A/en
Priority to EG20010701A priority patent/EG24742A/en
Priority to EP01960390.1A priority patent/EP1296715B2/en
Priority to EA200501070A priority patent/EA011480B1/en
Priority to PE2001000629A priority patent/PE20020126A1/en
Priority to DK01960390.1T priority patent/DK1296715T4/en
Priority to KR1020087013186A priority patent/KR100898845B1/en
Priority to PT07116669T priority patent/PT1946769E/en
Priority to MXPA03000198A priority patent/MXPA03000198A/en
Priority to ES07116669T priority patent/ES2385100T3/en
Priority to EP07116669A priority patent/EP1946769B1/en
Priority to EA200201240A priority patent/EA006313B1/en
Priority to IL153506A priority patent/IL153506A/en
Priority to NO20026175A priority patent/NO332495B1/en
Priority to MA26980A priority patent/MA25824A1/en
Priority to EC2002004406A priority patent/ECSP024406A/en
Priority to BG107422A priority patent/BG66238B1/en
Priority to ZA200300755A priority patent/ZA200300755B/en
Priority to HK03106153.7A priority patent/HK1055244A1/en
Priority to BG10110518A priority patent/BG66249B1/en
Priority to JP2010057779A priority patent/JP5346308B2/en
Priority to CY20121100103T priority patent/CY1112280T1/en
Priority to US13/439,829 priority patent/US9233151B2/en
Priority to CY20121100549T priority patent/CY1112915T1/en
Ceased legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
GBGB0015999.6A 2000-06-29 2000-06-29 Novel compounds Ceased GB0015999D0 (en)

Priority Applications (61)

Application Number Priority Date Filing Date Title
GBGB0015999.6A GB0015999D0 (en) 2000-06-29 2000-06-29 Novel compounds
HU0301413A HU228384B1 (en) 2000-06-29 2001-06-27 Vaccine compositions
AT01960390T ATE534402T1 (en) 2000-06-29 2001-06-27 MULTIVALENT VACCINE COMPOSITION
BR122012003821A BR122012003821B8 (en) 2000-06-29 2001-06-27 multivalent immunogenic composition, use thereof, and process to produce the immunogenic composition
OA1200200395A OA12302A (en) 2000-06-29 2001-06-27 Multivalent vaccine composition.
HU1000593A HU227893B1 (en) 2000-06-29 2001-06-27 Vaccine compositions
CN018146198A CN1449293B (en) 2000-06-29 2001-06-27 Multivalent vaccine composition
APAP/P/2002/002700A AP1695A (en) 2000-06-29 2001-06-27 Multivalent vaccine composition.
CZ20024224A CZ20024224A3 (en) 2000-06-29 2001-06-27 Pharmaceutical preparation
SI200131007T SI1296715T2 (en) 2000-06-29 2001-06-27 Multivalent vaccine composition
PL393584A PL393584A1 (en) 2000-06-29 2001-06-27 Vaccine
SK1843-2002A SK288007B6 (en) 2000-06-29 2001-06-27 Multivalent vaccine composition, process for its producing, and its use
ES01960390.1T ES2375704T5 (en) 2000-06-29 2001-06-27 Composition of multivalent vaccine
SI200131012T SI1946769T1 (en) 2000-06-29 2001-06-27 Multivalent vaccine composition with reduced dose of Haemophilus influenzae type B
DK07116669.8T DK1946769T3 (en) 2000-06-29 2001-06-27 Multivalent reduced dose vaccine composition of Haemophilus influenzae type B
KR1020027017928A KR100837917B1 (en) 2000-06-29 2001-06-27 Multivalent Vaccine Composition
DZ013399A DZ3399A1 (en) 2000-06-29 2001-06-27 VERSATILE VACCINE COMPOSITION
AU2001281895A AU2001281895C1 (en) 2000-06-29 2001-06-27 Vaccine Composition
PCT/EP2001/007288 WO2002000249A2 (en) 2000-06-29 2001-06-27 Multivalent vaccine composition
AU8189501A AU8189501A (en) 2000-06-29 2001-06-27 Vaccine composition
UY26801A UY26801A1 (en) 2000-06-29 2001-06-27 VACCINE COMPOSITION
IL15350601A IL153506A0 (en) 2000-06-29 2001-06-27 Multivalent vaccine composition
EP10178451A EP2277541A1 (en) 2000-06-29 2001-06-27 Multivalent vaccine composition
CA2412497A CA2412497C (en) 2000-06-29 2001-06-27 Vaccine composition
EP10178449A EP2279748A1 (en) 2000-06-29 2001-06-27 Multivalent vaccine composition
NZ523319A NZ523319A (en) 2000-06-29 2001-06-27 Vaccine compositions comprising Pw, TT, DT and H. influenzae type B (Hib) with a lower dose of Hib (5 mcg) compared with the standard does (10 mcg)
CA2783274A CA2783274C (en) 2000-06-29 2001-06-27 Multivalent vaccine composition with reduced dose of haemophilus influenza type b
UA20021210397A UA76952C2 (en) 2000-06-29 2001-06-27 Polyvalent immunogenic composition, method for its preparation, use for manufacturing drug for treatment and prevention of diseases caused by haemophilus influenzae type b, method of immunization against infections caused by haemophilus influenzae type b
PL360265A PL210015B1 (en) 2000-06-29 2001-06-27 Vaccine composition
CN200910174266.7A CN101708333B (en) 2000-06-29 2001-06-27 Multivalent vaccine composition
HU1000594A HU227613B1 (en) 2000-06-29 2001-06-27 Vaccine composition
US10/312,090 US20030180316A1 (en) 2000-06-29 2001-06-27 Multivalent vaccine composition
KR1020077019832A KR20070091698A (en) 2000-06-29 2001-06-27 Multivalent Vaccine Composition
PT01960390T PT1296715E (en) 2000-06-29 2001-06-27 Multivalent vaccine composition
BRPI0112057A BRPI0112057B8 (en) 2000-06-29 2001-06-27 multivalent immunogenic composition, and its use
JP2002505030A JP4870895B2 (en) 2000-06-29 2001-06-27 Vaccine composition
UAA200604994A UA85853C2 (en) 2000-06-29 2001-06-27 Multivalent vaccine composition
MYPI20013027 MY133981A (en) 2000-06-29 2001-06-27 Vaccine composition
EG20010701A EG24742A (en) 2000-06-29 2001-06-27 Vaccine composition.
EP01960390.1A EP1296715B2 (en) 2000-06-29 2001-06-27 Multivalent vaccine composition
EA200501070A EA011480B1 (en) 2000-06-29 2001-06-27 Multi-valent vaccine composition
PE2001000629A PE20020126A1 (en) 2000-06-29 2001-06-27 VACCINE COMPOSITION
DK01960390.1T DK1296715T4 (en) 2000-06-29 2001-06-27 Multivalent vaccine composition.
KR1020087013186A KR100898845B1 (en) 2000-06-29 2001-06-27 Multivalent vaccine composition
PT07116669T PT1946769E (en) 2000-06-29 2001-06-27 Multivalent vaccine composition with reduced dose of haemophilus influenzae type b
MXPA03000198A MXPA03000198A (en) 2000-06-29 2001-06-27 Vaccine composition.
ES07116669T ES2385100T3 (en) 2000-06-29 2001-06-27 Composition of multivalent vaccine with reduced dose of Haemophilus influenzae type B
EP07116669A EP1946769B1 (en) 2000-06-29 2001-06-27 Multivalent vaccine composition with reduced dose of Haemophilus influenzae type B
EA200201240A EA006313B1 (en) 2000-06-29 2001-06-27 Multi-valent immunogenic compositions and methods for using same
IL153506A IL153506A (en) 2000-06-29 2002-12-17 Multivalent vaccine composition
NO20026175A NO332495B1 (en) 2000-06-29 2002-12-20 Multivalent immunogenic preparation, as well as its use and preparation
MA26980A MA25824A1 (en) 2000-06-29 2002-12-26 VERSATILE VACCINE COMPOSITION
EC2002004406A ECSP024406A (en) 2000-06-29 2002-12-27 MULTIVALENT VACCINE COMPOSITION
BG107422A BG66238B1 (en) 2000-06-29 2002-12-28 Multivalent vaccine composition
ZA200300755A ZA200300755B (en) 2000-06-29 2003-01-28 Multivalent vaccine composition.
HK03106153.7A HK1055244A1 (en) 2000-06-29 2003-08-27 Multivalent vaccine composition
BG10110518A BG66249B1 (en) 2000-06-29 2009-11-06 Polyvalent vaccine composition
JP2010057779A JP5346308B2 (en) 2000-06-29 2010-03-15 Vaccine composition
CY20121100103T CY1112280T1 (en) 2000-06-29 2012-01-30 COMPOSITION OF A VARIETY VACCINE
US13/439,829 US9233151B2 (en) 2000-06-29 2012-04-04 Vaccine composition
CY20121100549T CY1112915T1 (en) 2000-06-29 2012-06-15 COMPOSITION OF A VULNERABLE VACCINE WITH REDUCED TYPE B FLU

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0015999.6A GB0015999D0 (en) 2000-06-29 2000-06-29 Novel compounds

Publications (1)

Publication Number Publication Date
GB0015999D0 true GB0015999D0 (en) 2000-08-23

Family

ID=9894692

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0015999.6A Ceased GB0015999D0 (en) 2000-06-29 2000-06-29 Novel compounds

Country Status (3)

Country Link
EC (1) ECSP024406A (en)
GB (1) GB0015999D0 (en)
ZA (1) ZA200300755B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102302776A (en) * 2003-01-30 2012-01-04 诺华疫苗和诊断有限公司 Injectable vaccines against multiple meningococcal serogroups

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102302776A (en) * 2003-01-30 2012-01-04 诺华疫苗和诊断有限公司 Injectable vaccines against multiple meningococcal serogroups

Also Published As

Publication number Publication date
ECSP024406A (en) 2003-04-25
ZA200300755B (en) 2004-04-28

Similar Documents

Publication Publication Date Title
AU7476301A (en) Novel compounds
EP1276755A4 (en) Novel compounds
AU9261901A (en) Novel compounds
GB0003019D0 (en) Novel compounds
EP1255771A4 (en) Novel compounds
GB0008464D0 (en) Novel compounds
EP1292617A4 (en) Novel compounds
EP1472352A4 (en) Novel compounds
EP1343813A4 (en) Novel compounds
AU7476401A (en) Novel compounds
EP1276866A4 (en) Novel compounds
GB0004149D0 (en) Novel compounds
EP1299530A4 (en) Novel compounds
GB0001898D0 (en) Novel compounds
GB0003636D0 (en) Novel compounds
GB0004196D0 (en) Novel compounds
GB0002402D0 (en) Novel compounds
EG22332A (en) Novel compounds
GB0000928D0 (en) Novel compounds
GB0004269D0 (en) Novel compounds
GB0002330D0 (en) Novel compounds
GB0002401D0 (en) Novel compounds
GB0002191D0 (en) Novel compounds
GB0002096D0 (en) Novel compounds
GB0003023D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)